Navigation Links
Haemacure Announces Preliminary Findings of its Plasma Discard,Analysis

sma-derived protein market is estimated to reach US$8.5 billion by 2010. The North American market was estimated at US$2.4 billion in 2006. Immunoglobulin is the biggest selling protein in North America, with sales estimated at US$1.4 billion in 2006 in the United States alone. Immunoglobulin is used to treat immunological, neurological and other disorders. Plasminogen, once converted into plasmin, is a clot buster and offers a natural alternative to synthesized solutions to address an unmet need of the market. A1PI is used by patients suffering from hereditary emphysema resulting from A1PI deficiency. A1PI deficiency affects between 60,000 to 100,000 people in the United States.

According to Cowen and Company, enzyme replacement therapies (ERTs) will reach US$3.1B in 2011. ERTs are the cornerstone of treatment of many orphan disorders, particularly the lysosomal storage diseases. Orphan diseases are comprised of number different conditions that each afflict only a small number of individuals, but together constitute one of the most lucrative therapeutic areas. The four leading lysosomal disorder products are intended to treat Gaucher's disease, Fabry's disease, Hurler's disease and Pompe's disease.

In 2006, estimated sales for these four leading lysosomal disorder products were US$1 billion, US$359 million, US$96 million and US$30 million respectively, nearly US$1.5 billion in total. Haemacure has identified in its plasma discard enzymes each treating one of these diseases. The enzymes are alpha-galactosidase, used to treat Fabry's disease, alpha-glucosidase, used to treat Pompe's disease, beta-glucosidase, used to treat Gaucher's disease, and alpha-iduronidase, used to treat Hurler's disease.

Haemacure has also identified three other enzymes, used to treat Hunter's disease, Morquio's disease and Shindler's disease. Products are also in development for these diseases.

As advised, these findings are preliminary and the full value of these
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:9/29/2014)... YORK , Sept. 29, 2014 EU5 ... Summary GlobalData,s new report, "EU5 Capsule ... data on the EU5 Capsule Endoscopy Systems market. The ... (in units) and average prices (in US dollars) within ... and Capsule Endoscopy Workstations. The report also ...
(Date:9/29/2014)... Pharmaceutical Care Management Association (PCMA) President and ... that could reduce prescription fraud and abuse in Medicare ... Opioid Abuse: Fighting Back on Many Fronts ," sponsored ... The briefing featured several government and industry ... fraud. The Centers for Disease Control and Prevention has ...
(Date:9/29/2014)... LAKE CITY , Sept. 29, 2014 /PRNewswire/ ... has scheduled a conference call for investors today ... for the quarter and year ended June 30, ... in participating is (800) 771-7941. Dynatronics ... soft goods and supplies, treatment tables and rehabilitation ...
Breaking Medicine Technology:EU5 Capsule Endoscopy Systems Market Outlook to 2020 2EU5 Capsule Endoscopy Systems Market Outlook to 2020 3PCMA: How Congress Can Fight Prescription Drug Fraud and Abuse 2
... 2011 Genomic Health, Inc. (Nasdaq: GHDX ) today ... on Wednesday, August 3 at 4:30 p.m. Eastern Time to discuss ... follow the release of the second quarter financial results after market ... To access the live conference call on August 3 at ...
... July 27, 2011 For men facing radical prostatectomy ... not their only concern. In fact, a large number of ... continence among their biggest fears. More than 240,000 men will ... patients of Dr. David Samadi,s, Vice Chairman, Department of Urology, ...
Cached Medicine Technology:Genomic Health to Announce Second Quarter 2011 Financial Results and Host Conference Call on Wednesday, August 3, 2011 2Genomic Health to Announce Second Quarter 2011 Financial Results and Host Conference Call on Wednesday, August 3, 2011 3Post Robotic Prostate Surgery Continence and Pelvic Floor Muscles 2Post Robotic Prostate Surgery Continence and Pelvic Floor Muscles 3
(Date:9/30/2014)... 2014 A highlight for this year’s ... the American Academy of Ophthalmology meeting in Chicago will ... Jeffrey Martin, MD on the latest advances in ... Partner of North Shore Eye Care and is an ... , This year’s 118th Annual American Academy of Ophthalmology ...
(Date:9/30/2014)... 2014 (HealthDay News) -- In books and movies, plots involving ... Now, new research suggests that the stereotype may be ... at data on more than 12,000 people from Finland. ... Turku, Finland, found that women typically preferred men who were ... throughout their lives. On the other hand, men tended ...
(Date:9/30/2014)... ARBORResearchers at the University of Michigan have described a ... a fraction of the time needed for more traditional ... a novel antibody that is undergoing further investigation as ... , In research published online in ... , researchers in the lab of Stephen Weiss at ...
(Date:9/30/2014)... MYERS, Fla. (PRWEB) September 30, 2014 ... Hospital, is giving breast cancer patients a new, more ... surgeries. , Women who undergo mastectomies, biopsies and lumpectomy ... and promote healing. But after seeing her patients describe ... felt compelled to create a new bra in her ...
(Date:9/30/2014)... Florida (PRWEB) September 30, 2014 Brig ... in history, who broke over 500 Diamond-ranked professionals using ... is doing it again. The Life Support System ... systems he has been perfecting using his experiences and ... this month. Using the principles and methodology taught by ...
Breaking Medicine News(10 mins):Health News:Global Laser Technology Leader Selects Jeffrey Martin, MD To Address Colleagues During International Symposium In Chicago 2014 2Health News:Global Laser Technology Leader Selects Jeffrey Martin, MD To Address Colleagues During International Symposium In Chicago 2014 3Health News:When It Comes to Sex Partners, Men Prefer Younger Women: Study 2Health News:New discovery approach accelerates identification of potential cancer treatments 2Health News:Surgeon Creates New Bra for Breast Cancer Patients, Post-Surgery 2Health News:Surgeon Creates New Bra for Breast Cancer Patients, Post-Surgery 3Health News:Brig Hart Announces the First Diamond Elite Representatives using his Life Support System 2Health News:Brig Hart Announces the First Diamond Elite Representatives using his Life Support System 3
... urged Australians to spare a thought this week for those ... of year for most people means joyful gatherings with friends ... despair,' Dr Yong said. ,'The social circuit, gift-giving ... cause depression for those who are socially isolated. ...
... of Alzheimer's disease (AD) according to a study conducted ... one// in a group of related steroid hormones referred ... in the December 20 issue of The Journal of ... loss and AD, which affects 4.5 million Americans. ...
... .But for about 10% to 20 % of women menopausal ... night sweats, hot// flashes (sensation of heat which comes on ... Replacement Therapy (HRT) is the conventional treatment of choice that ... menopausal period. Hormone therapy offers great relief from hot flashes ...
... Sharad Pawar was Tuesday admitted to a hospital here ... ,The Nationalist Congress Party (NCP) chief was on way ... in the evening when he complained of ill health. ... south Delhi. ,"He is under observation," said ...
... Anbumani Ramadoss Monday stressed the need for inter-state ... drugs.// ,"States should create a good system ... on the culprits. They should share the information ... menace," Ramadoss said., ,Inaugurating the 37th Drug ...
... a new anti-rabies vaccine Rabirix that can be used ... of infection due to animal bite or contact with ... been indigenously developed by BBIL and "can be used ... treatments", said Krishna M. Ella, chairman and managing director ...
Cached Medicine News:Health News:Increase Testosterone Levels To Slow Down Alzheimer’ 2Health News:Natural Remedies Ineffective to Ease Menopausal Symptoms:study 2Health News:Bharat Biotech Launches Anti-Rabies Vaccine 2
... EZLink was designed to provide optimal ... associated with a larger network system. Most ... - up to three workstations located in ... features and performance. For creating a paperless ...
A comprehensive and cost effective LIS solution for the Physicians Office Laboratory....
LabPak II is a comprehensive multi-user Laboratory Information System designed to meet the requirements of the larger POL, small hospital or private laboratory. It is the next step up from the LabPak...
... BMP™ Total Hip Pouch Drape is designed as an ... to dislocate the lower extremity into a sterile pouch ... clear poly and is a generous 60 inches long ... the extremity with a 4 inch wide adhesive strip ...
Medicine Products: